Tel/PDGFRβ induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways

These findings suggest that targeted disruption of key signaling pathways in combination with the tyrosine kinase activity of leukemic oncogenes, such as Tel/PDGFRβ, may result in more efficacious therapies for suppressing leukemic progression in the clinical setting.